FIELD: medicine.
SUBSTANCE: invention relates to medicine and describes method of evaluating efficiency of dialysis-filtration purification of blood, which consists in the fact that total concentration of phenylacetic (PAC), para-hydroxyphenylacetic (p-HPAC), phenyllactic (PLA) and para-hydroxyphenyllactic (p-HPLA) acids is determined in patient's blood serum before and after blood purification, and if it reduces 2 and more times, blood purification is considered effective.
EFFECT: method has high methodical accuracy and objectiveness and makes it possible to determine efficiency of performed operation of blood purification in patients with different diseases in due time.
8 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR LABORATORY ASSESSMENT OF EFFECTIVENESS IN TREATMENT OF INTOXICATION IN EMERGENCY PATIENTS | 2012 |
|
RU2522877C2 |
| METHOD FOR LABORATORY ASSESSMENT OF EFFICACY OF ANTIBACTERIAL THERAPY | 2012 |
|
RU2543335C2 |
| LABORATORY DIAGNOSTIC TECHNIQUE FOR SEPSIS | 2009 |
|
RU2423704C1 |
| METHOD FOR DETERMINATION OF AROMATIC MICROBIAL METABOLITES IN THE FORM OF PHENYLCARBOXYLIC ACIDS IN THE BLOOD SERUM | 2017 |
|
RU2663571C1 |
| METHOD FOR ASSESSING THE RISK OF BACTERIAL MENINGITIS IN CRITICALLY ILL PATIENTS | 2021 |
|
RU2759025C1 |
| METHOD FOR TREATING THE CASES OF RENAL INSUFFICIENCY | 1998 |
|
RU2154499C2 |
| METHOD FOR INTENSIVE THERAPY OF MULTIPLE ORGAN FAILURE IN PATIENTS WITH POLYTRAUMA | 2013 |
|
RU2523452C1 |
| METHOD FOR PREVENTING RENAL DAMAGE IN PATIENTS WITH A PRIMARILY IDENTIFIED SECRETING MULTIPLE MYELOMA | 2017 |
|
RU2652082C1 |
| METHOD FOR ESTIMATION OF PATIENT STATE SEVERITY AND RISK OF LETHAL OUTCOME BASED ON PHENYLMOCAL ACID LEVEL IN BLOOD | 2015 |
|
RU2623148C2 |
| METHOD FOR CONTROLLING QUALITY OF DIALYSIS THERAPY | 1999 |
|
RU2152040C1 |
